Kalaris Therapeutics, Inc. (KLRS)
3.38
+0.08
(+2.42%)
USD |
NASDAQ |
Sep 11, 16:00
3.42
+0.04
(+1.18%)
After-Hours: 20:00
Kalaris Therapeutics Market Cap : 80.46M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 80.46M |
| September 10, 2026 | 78.56M |
| September 09, 2026 | 82.60M |
| September 08, 2026 | 86.41M |
| September 04, 2026 | 92.84M |
| September 03, 2026 | 93.79M |
| September 02, 2026 | 92.84M |
| September 01, 2026 | 93.32M |
| August 31, 2026 | 96.17M |
| August 28, 2026 | 95.93M |
| August 27, 2026 | 97.60M |
| August 26, 2026 | 97.12M |
| August 25, 2026 | 99.98M |
| August 24, 2026 | 97.60M |
| August 21, 2026 | 98.79M |
| August 20, 2026 | 98.08M |
| August 19, 2026 | 99.27M |
| August 18, 2026 | 95.93M |
| August 17, 2026 | 94.27M |
| August 14, 2026 | 97.12M |
| August 13, 2026 | 92.36M |
| August 12, 2026 | 93.79M |
| August 11, 2026 | 94.51M |
| August 10, 2026 | 93.79M |
| August 07, 2026 | 96.89M |
| Date | Value |
|---|---|
| August 06, 2026 | 96.34M |
| August 05, 2026 | 96.34M |
| August 04, 2026 | 99.33M |
| August 03, 2026 | 93.12M |
| July 31, 2026 | 80.70M |
| July 30, 2026 | 80.01M |
| July 29, 2026 | 78.17M |
| July 28, 2026 | 76.79M |
| July 27, 2026 | 82.31M |
| July 24, 2026 | 85.76M |
| July 23, 2026 | 90.13M |
| July 22, 2026 | 93.58M |
| July 21, 2026 | 92.89M |
| July 20, 2026 | 91.97M |
| July 17, 2026 | 100.71M |
| July 16, 2026 | 105.99M |
| July 15, 2026 | 110.82M |
| July 14, 2026 | 104.62M |
| July 13, 2026 | 101.63M |
| July 10, 2026 | 102.09M |
| July 09, 2026 | 103.24M |
| July 08, 2026 | 108.29M |
| July 07, 2026 | 111.05M |
| July 06, 2026 | 106.91M |
| July 02, 2026 | 109.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Replimune Group, Inc. | 1.085B |
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
| Oncolytics Biotech, Inc. | 92.92M |
| Sangamo Therapeutics, Inc. | 61.52M |
| Sarepta Therapeutics, Inc. | 2.160B |
Market Cap Related Metrics
| Price to Book Value | 1.395 |
| Price | 3.38 |
| Earnings Yield | -59.59% |